Robert Szulkin is a senior consultant in statistics at SDS Life Science. His main area of expertise is within the fields of epidemiology and biostatistics. He has 15+ years of experience working with register studies, including methods related to observational studies. As a consultant, his primary focus is Real-world evidence studies for industrial clients and providing support on academic projects. He is also frequently engaged as a lecturer in biostatistics by universities and Pharmacology companies.
Articles and columns by Robert Szulkin
Expertise in epidemiology and statistics
4 Crucial Challenges in real-world evidence (RWE) studies
Planning and conducting a real-world evidence study can be very challenging. In this article, SDS consultant Dr. Robert Szulkin breaks down four crucial challenges when conducting an RWE study.
What is real-world evidence (RWE) and and why do we need it?
It is has been long established that it is essential to conduct randomized controlled studies as part of the drug development process. However, these “high-level evidence” studies are not always sufficient to get approval from the regulatory bodies. Often, additional evidence from so-called “Real World Evidence” studies is required. Dr Robert Szulkin explains.